← Leaderboards
Mohammed Dwidar
Cleveland Clinic Lerner Com-Cwru
$811,955
Attributed
$811,955
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.5K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$811,955 · 2
By mechanism
R21$409,455 · 1
R35$402,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Paul L Fox$31,501,589
- Jae U Jung$74,270,295
- Srinivasan Dasarathy$21,059,442
- Serpil C. Erzurum$45,061,611
- Ariel Feldstein$9,492,610
Others in their field
Other Rising Stars on “Synthetic Biology”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Chase Kempinski · Enepret, Inc.$3,595,837
- Vasu Sethuraman · Syntis Bio Inc$3,502,495
- Sarah Sterman · University Of Illinois At Urbana-Champaign$3,250,000
- Yun Chen · Johns Hopkins University$3,000,000
Research focus
Synthetic BiologyCuesResponseTissuesPhysiologicalAreaEngineeringProductionSpecific Qualifier ValueTumorSolid NeoplasmBacteriaFutureBreastBrainAptamerClinical TreatmentAcidityClinical TrialsColon CarcinomaCell MotilityCell LineCessation Of LifeBacterial Adhesins
Grant awards (3)
Synthetic biology tools and strategies to streamline the sensing and responding to disease cues in engineered theragnostic bacteria.$402,500
R35 · FY2025 · GM · contact PI
Cancer-specific metabolites as cues to engineer and target anti-tumor therapeutic bacteria$221,286
R21 · FY2023 · CA · contact PI
Cancer-specific metabolites as cues to engineer and target anti-tumor therapeutic bacteria$188,169
R21 · FY2022 · CA · contact PI